Simulating Trial Design Impact on Enrollment Automation

This workflow automates the bottleneck of manual, error-prone trial feasibility studies. By creating a digital twin of the target patient population from real-world data, it allows sponsors to simulate how adjustments to inclusion/exclusion criteria, endpoints, or visit schedules affect recruitability before protocol lock. The business value is direct: reducing costly protocol amendments, cutting months from startup timelines, and preventing under-enrollment by quantifying the operational impact of every design choice. Implementation requires orchestrating agents to query RWE sources, apply logic, and generate scenario reports.

Architecturally, the core is a simulation orchestrator (e.g., built with LangGraph) that coordinates data agents, a scenario engine, and predictive models. It ingests from EHRs (Epic, Cerner), claims databases, and historical trial performance systems. The output is a governed report forecasting cohort size, enrollment curves, and site burden, routed through a medical/operational review gate before updating the final protocol in systems like Veeva Vault. Controls are critical: all simulations run on de-identified or synthetic data, recommendations require human approval, and full audit trails are maintained for regulatory defensibility.

This automation replaces manual, spreadsheet-based feasibility studies with a dynamic digital twin of the patient population. Orchestration agents ingest protocol drafts, map criteria to real-world data ontologies, and execute thousands of simulation scenarios against harmonized EHR and claims data. The result is a quantified impact analysis on potential cohort size, diversity, and geographic distribution, delivered in hours instead of weeks, directly informing protocol amendments to reduce costly mid-study enrollment delays.

Implementation integrates with Veeva Vault for protocol management and uses LangGraph to coordinate simulation agents, each responsible for criteria parsing, data querying, or statistical modeling. Critical controls include a mandatory human-in-the-loop review gate for all recommended protocol changes and continuous bias monitoring on simulation outputs. This architecture provides sponsors with a defensible, audit-ready system for optimizing trial design, directly targeting multi-million dollar costs associated with enrollment shortfalls and protocol amendments.

The workflow automates the bottleneck of manual, spreadsheet-based feasibility analysis. It ingests historical EHR and claims data to create a digital twin of the target patient population. Simulation agents then test hundreds of protocol variations—adjusting inclusion/exclusion criteria, visit schedules, and endpoints—to project their impact on eligible cohort size, geographic distribution, and estimated enrollment timelines. This replaces weeks of analyst work with hours of automated scenario testing, directly reducing costly protocol amendments and enrollment delays.

Implementation follows a phased delivery: Phase 1 builds the core simulation engine using synthetic data within a secure VPC, integrating with a sample protocol repository. Phase 2 connects to de-identified real-world data sources like TriNetX or Flatiron, adding governance controls for data use. Phase 3 integrates the output directly into clinical trial management systems (CTMS) like Veeva Vault, enabling automated updates to site activation and enrollment plans based on the optimized protocol. Each phase delivers measurable ROI in planning speed and reduced protocol rework.

This workflow automates the bottleneck of manual, spreadsheet-based protocol feasibility analysis. By creating a digital twin of the target patient population from historical EHR and claims data, it allows sponsors to simulate dozens of inclusion/exclusion criteria and endpoint scenarios in hours, not weeks. The operational upside is direct: reducing costly protocol amendments and enrollment delays by stress-testing design assumptions against real-world data before finalizing the study. This requires integration with RWE platforms, protocol repositories, and a governed simulation engine.

Implementation follows a phased rollout, starting with a single therapeutic area and historical data sandbox. The first phase validates the simulation model's output against known historical trial outcomes. The second phase integrates live, privacy-preserving federated queries from partner health networks for real-time validation. Governance is critical: each simulation run and its underlying assumptions are version-controlled and logged. A formal change control board—comprising clinical, statistical, and operational leads—must approve any protocol amendment triggered by simulation insights before deployment to active site outreach.

This workflow automates the bottleneck of manual, speculative protocol design by creating a digital twin of your target patient population. It ingests real-world data from EHRs, claims, and genomic sources to simulate how adjustments to inclusion/exclusion criteria, endpoints, or visit schedules will affect eligible cohort size, diversity, and projected enrollment timelines. The operational upside is clear: reduce costly protocol amendments and enrollment delays by stress-testing design feasibility in silico, turning months of manual analysis into hours of automated scenario modeling.

Implementation requires integrating simulation agents with RWE platforms like TriNetX or Flatiron, and orchestrating them via LangGraph or a custom engine. Key controls include governance gates for medical review of simulated criteria, bias detection in resulting cohorts, and audit trails linking simulation parameters to final protocol decisions. The output is a validated, data-backed protocol and a pre-populated feasibility model in your CTMS, de-risking the entire enrollment operation before site activation begins.